Journal
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 16, Issue 5, Pages 694-704Publisher
AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.16091020
Keywords
geriatric nephrology; chronic kidney disease; cognitive dysfunction; gait
Categories
Funding
- National Institutes of Health [K23DK099438, R01AG036921, R01AG044007]
- Resnick Gerontology Center, Albert Einstein College of Medicine, intramural grant
Ask authors/readers for more resources
In older adults with CKD, the gait phenotype is associated with cognitive dysfunction, showing poorer function in various cognitive domains. Neuroimaging reveals a pattern of gray matter atrophy linked with cognition in both CKD and the gait phenotype.
Background and objectives Cognitive impairment is a major cause of morbidity in CKD. We hypothesized that gait abnormalities share a common pathogenesis with cognitive dysfunction in CKD, and therefore would be associated with impaired cognitive function in older adults with CKD, and focused on a recently defined gait phenotype linked with CKD. Design, setting, participants,& measurements Gait assessments and neuropsychological testing were performed in 312 nondisabled, community-dwelling older adults (aged >= 65 years). A subset (n=115) underwent magnetic resonance imaging. The primary cognitive outcome was the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) total scale score. Associations with cognitive function were tested using multivariable linear regression and nearest-neighbor matching. The risk of developing mild cognitive impairment syndrome was assessed using Cox proportional hazards models. Results Lower eGFR was associated with lower RBANS score only among participants with the gait phenotype (P for interaction =0.04). Compared with participants with neither CKD nor the gait phenotype, adjusted RBANS scores were 5.4 points (95% confidence interval, 1.8 to 9.1) lower among participants with both, who demonstrated poorer immediate memory, visuospatial ability, delayed memory, and executive function. In a matched analysis limited to participants with CKD, the gait phenotype was similarly associated with lower RBANS scores (-6.9; 95% confidence interval, -12.2 to -1.5). Neuroimaging identified a pattern of gray matter atrophy common to both CKD and the gait phenotype involving brain regions linked with cognition. The gait phenotype was associated with higher risk of mild cognitive impairment (hazard ratio, 3.91; 95% confidence interval, 1.46 to 10.44) independent of eGFR. Conclusions The gait phenotype was associated with poorer function in a number of cognitive domains among older adults with CKD, and was associated with incident mild cognitive impairment independent of eGFR. CKD and the gait phenotype were associated with a shared pattern of gray matter atrophy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available